Zealand Pharma plans to open a new research facility in Boston, part of the obesity drugmaker’s effort to expand its presence in the US. The Danish company will likely hire between 50 and 100 people ...

A collage of images including people in a lab, Chinese currency, and a person wearing full personal protective gear and ...

Oaktree Capital Management is considering a $300 million investment in a bankrupt biotechnology fund that Russian billionaire Dmitry Rybolovlev’s family trust is seeking to shut down.

Servier’s deal rewrites DAWN’s technical profile, valuing its shares at $21.5 each, which translates to a nearly 70% upside from its previous close. Following this explosive move to the upside, Day ...

The Supreme Court has dismissed a criminal appeal filed by SBS Biotech and its officials, upholding the Himachal Pradesh High ...

Germany's Merck KGaA projected 2026 adjusted operating profit to slip by as much as ​9.8%, hurt by negative currency effects and the loss of ​patent protection for a multiple sclerosis drug.

Tanager Wealth Management exited its entire CNTA position, reducing holdings by 598,044 shares in the fourth quarter. As a result, the quarter-end position value decreased by $14.50 million, ...

SAN FRANCISCO, CA / ACCESS Newswire / March 4, 2026 / Tivic Health Systems, Inc. (Nasdaq:TIVC) ("Tivic" or the "Company"), a late-stage immunotherapeutics company, today announced that its Board of ...

New drugs and lucrative markets in the US remain crucial to Europe’s pharma sector, as governments approach closer trade with Asia.

Charles River Laboratories International, Inc. ( CRL) TD Cowen 46th Annual Health Care Conference March 3, 2026 9:50 AM EST ...

Herantis Pharma: Disclosure of Major Holdings according to Chapter 9, Section 10 of the Finnish Securities Markets Act ...

Acadia Pharmaceuticals Inc. (NASDAQ:ACAD) will request a re-examination of a negative opinion from the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) on its ...